Our Pipeline
Our company grows out of the research of co-founder Dr. Michael R. Rose, professor of evolutionary biology at the University of California, Irvine (Google Scholar). This research applies quantitative genetics, experimental evolution, and genome-wide sequencing to the problem of aging. Over the last few decades, we have been working on the development of faster and more powerful ways to develop pharmaceuticals for chronic disorders of aging.
World class genomics expertise
We have been publishing world-class genomics since 2010. Our particular focus has been parsing entire genomes for the key determinants of aging and its associated chronic diseases.
Genomically differentiated animal populations
Our key resource is a large collection of Drosophila populations that we have evolved to improve aging and chronic disease. These populations are not inbred mutants. Instead, like humans, they are outbred and physiologically robust.
Genomic insights into chronic diseases
We have developed new statistical approaches to determining the most important genomic sites and pathways underlying chronic diseases. With our animal resources and our genomic information, we have great inferential power for determining the biological foundations of chronic diseases, as well as for drug discovery.